{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Answers from the Lab","title":"WESDX: Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/393090bd\"></iframe>","width":"100%","height":180,"duration":685,"description":"Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. This comprehensive, next-generation sequencing evaluation investigates approximately 20,000 genes for variations associated with genetic disease. Recommended by the American College of Medical Genetics and Genomics as a first-line test for individuals with one or more congenital abnormalities, WES enables individualized insights on genetic variants that can facilitate diagnosis, prognosis, and management decisions.","thumbnail_url":"https://img.transistorcdn.com/jhRCftFebxnTMwoIbA_WoqrSKwFRD_Y2kbh0JDjhx14/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjNj/ZDc0NTE0MWNlOWRl/YzRiN2Q3NDg2Mjg5/YWE4MS5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}